Opposite behavior of plasma levels surfactant protein type B and receptor for advanced glycation end products in pulmonary sarcoidosis

Respiratory Medicine

Volumn 107, Issue 10, 2013, Pages 1617-1624

  Magrì, Damiano ^a   Mariotta, Salvatore ^a   Banfi, Cristina ^b   Ricotta, Agnese ^a   Onofri, Alessandro ^a   Ricci, Alberto ^a   Pisani, Lara ^a   Cauti, Filippo Maria ^a   Ghilardi, Stefania ^b   Agostoni, Piergiuseppe ^b,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cardiopulmonary exercise test; Lung diffusion capacity; Pulmonary sarcoidosis; RAGE; Surfactant protein type B

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CARBON MONOXIDE; SURFACTANT PROTEIN B;

ADULT; ARTICLE; BODY SURFACE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL STATUS; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN TISSUE; LUNG DIFFUSION; LUNG FUNCTION; LUNG SARCOIDOSIS; MALE; PATIENT; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

CARDIOPULMONARY EXERCISE TEST; LUNG DIFFUSION CAPACITY; PULMONARY SARCOIDOSIS; RAGE; SURFACTANT PROTEIN TYPE B;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY DIFFUSING CAPACITY; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; RECEPTORS, IMMUNOLOGIC; SARCOIDOSIS, PULMONARY; VITAL CAPACITY;

EID: 84884817970     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.07.019     Document Type: Article

References (40)

1. R.C. Iannuzzi, Ba Rybicki, and A.S. Teirstein Sarcoidosis N Engl J Med 357 2007 2153 2165
2. D.Y. Sue, A. Oren, J.E. Hansen, and K. Wasserman Diffusing capacity for carbon monoxide as a predictor of gas exchange during exercise N Engl J Med 316 1987 1301 1306
3. T. Takemura, Y. Matsui, S. Saiki, and R. Mikami Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases Hum Pathol 23 1992 1216 1223
4. C. Lamberto, H. Nunes, P. Le Toumelin, F. Duperron, D. Valeyre, and C. Clerici Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis. Relation to exercise gas exchange Chest 125 2004 2061 2068
5. D. Magrì, P. Agostoni, A. Ricotta, L. Pisani, F.M. Cauti, and A. Onofri NT-proAtrial Natriuretic Peptide as a possible biomarker of cardiopulmonary involvement in sarcoidosis Eur J Intern Med 24 2013 278 284
6. C. Emirgil, B.J. Sobol, W.H. Herbert, and K. Trout The lesser circulation in pulmonary fibrosis secondary to sarcoidosis and its relationship to respiratory function Chest 60 1971 371 378
7. H. Nunes, M. Humbert, F. Capron, M. Brauner, O. Sitbon, and J.P. Battesti Pulmonary hypertension associated with sarcoidosis, haemodynamics and prognosis Thorax 61 2006 68 74
8. A. Tzouvelekis, G. Kouliatsis, S. Anevlavis, and D. Bouros Serum biomarkers in interstitial lung diseases Respir Res 21 6 2005 78
9. J. Goerke Pulmonary surfactant: functions and molecular composition Biochim Biophys Acta 1408 1998 79 89
10. A.G. Serrano, and J. Perez-Gil Protein-lipid interaction and surface activity in the pulmonary surfactant system Chem Phys Lipids 141 2006 105 118
11. C.G. De Pasquale, L.F. Arnolda, I.R. Doyle, R.L. Grant, P.E. Aylward, and A.D. Bersten Prolonged alveolocapillary barrier damage after acute cardiogenic pulmonary edema Crit Care Med 31 2003 1060 1067
12. D. Magrì, M. Brioschi, C. Banfi, J.P. Schmid, P. Palermo, and M. Contini Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure Circ Heart Fail 2 2009 175 180
13. P. Agostoni, C. Banfi, D. Magrì, C. Vignati, E. Doria, and E. Salvioni Kinetics of plasma SP-B and RAGE during mechanical ventilation in patients undergoing major vascular surgery Respir Physiol Neurobiol 178 2011 256 260
14. P. Agostoni, C. Banfi, M. Brioschi, D. Magrì, S. Sciomer, and G. Berna Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study Eur Respir J 37 2011 841 847
15. T. Uchida, M. Shirasawa, L.B. Ware, K. Kojima, Y. Hata, and K. Makita Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury Am J Respir Crit Care Med 173 2006 1008 1015
16. T.K. Mukherjee, S. Mukhopadhyay, and J.R. Hoidal Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology Respir Physiol Neurobiol 162 2008 210 215
17. S.T. Buckley, and C. Ehrhardt The receptor for advanced glycation end products (RAGE) and the lung J Biomed Biotechnol 2010 917108
18. M.A. Queisser, F.M. Kouri, M. Konigshoff, M. Wygrecka, U. Schubert, and O. Eickelberg Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types Am J Resp Cell Mol Biol 39 2008 337 345
19. C. Risk, G.R. Epler, and E.A. Gaensler Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease Chest 85 1984 69 74
20. C.C. Hsia Recruitment of lung diffusing capacity: update of concept and application Chest 122 2002 1774 1783
21. Statement of sarcoidosis: joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999 Am J Respir Crit Care Med 160 1999 736 755
22. Official statement of the ATS: standardization of spirometry Am J Respir Crit Care Med 152 1995 1107 1136
23. J.E. Cotes, D.J. Chinn, P.H. Quanjer, J. Roca, and J.C. Yernault Standardization of the measurement of transfer factor (diffusing capacity): report Working Party Standardization of Lung Function Tests, European Community for Coal and Steel; official position of the European Respiratory Society Eur Respir J Suppl 16 1993 41 52
24. S. Sciomer, D. Magrì, and R. Badagliacca Non-invasive assessment of pulmonary hypertension: Doppler-echocardiography Pulm Pharmacol Ther 20 2007 135 140
25. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards Committee, and European Association of Echocardiography Recommendation for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standard Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Society of Echocardiograph, a brunch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
26. P. Agostoni, M. Bianchi, A. Moraschi, P. Palermo, G. Cattadori, and R. La Gioia Work-rate affects cardiopulmonary exercise test results in heart failure Eur J Heart Fail 7 2005 498 504
27. K. Wasserman, J.E. Hansen, D.Y. Sue, R. Casaburi, and B.J. Whipp Principles of exercise testing and interpretation 4th ed. 2005 Lippincott Williams & Wilkins Baltimore 10 65
28. M.F. Piepoli, U. Corrà, P.G. Agostoni, R. Belardinelli, A. Cohen-Solal, R. Hambrecht Task Force of the Italian Working Group on Cardiac Rehabilitation Prevention, and Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendation for performance and interpretation. I. Definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure Eur J Cardiovasc Prev Rehabil 13 2006 150 164
29. 2 and exercise performance in healthy subjects Eur J Appl Physiol 103 2008 727 732
30. P. Agostoni, M. Valentini, D. Magrí, M. Revera, G. Caldara, and F. Gregorini Disappearance of isocapnic buffering period during increasing work rate exercise at high altitude Eur J Cardiovasc Prev Rehabil 15 2008 354 358
31. A.D. Bersten, T. Hunt, T.E. Nicholas, and I.R. Doyle Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure Am J Respir Crit Care Med 164 2001 648 652
32. C.G. De Pasquale, L.F. Arnolda, I.R. Doyle, P.E. Aylward, A.E. Russell, and A.D. Bersten Circulating surfactant protein-B levels increase acutely in response to exercise-induced left ventricular dysfunction Clin Exp Pharmacol Physiol 32 2005 622 627
33. F.X. Kleber, G. Vietzke, K.D. Wernecke, U. Bauer, C. Opitz, and R. Wensel Impairment of ventilator efficiency in heart failure: prognostic impact Circulation 101 2000 2803 2809
34. C.S. Calfee, M.M. Budev, M.A. Matthay, G. Church, S. Brady, and T. Uchida Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation J Heart Lung Transplant 26 2007 675 680
35. P.G. Agostoni, E.R. Swenson, R. Fumagalli, E. Salvioni, G. Cattadori, and S. Farina Acute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project Respir Physiol Neurobiol 2013 http://dx.doi.org/10.1016/j. resp.2013.04.005
36. J.M. Englert, L.E. Hanford, N. Kaminski, J.M. Tobolewski, R.J. Tan, and C.L. Fattman A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis Am J Pathol 172 2008 583 591
37. M. Selman, G. Carrillo, A. Estrada, M. Mejia, C. Becerril, and J. Cisneros Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern PLoS One 2 2007 e482
38. E. Bargagli, F. Penza, N. Bianchi, C. Olivieri, D. Bennett, and A. Prasse Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis Respir Physiol Neurobiol 165 2009 119 120
39. L. Chen, T. Wang, X. Wang, B.B. Sun, J.Q. Li, and D.S. Liu Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats Respir Res 10 2009 55
40. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J Clin Invest 108 2001 949 955